Cargando…
Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands
Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-regulated transcription factor that plays crucial roles in adipogenesis, lipid metabolism, and glucose homeostasis. Several PPARγ ligands possess anti-diabetic activity and they commonly inhibit the phosphorylation of PPARγ at seri...
Autores principales: | Bae, Hwan, Jang, Jun Young, Choi, Sun-Sil, Lee, Jae-Jin, Kim, Heejun, Jo, Ala, Lee, Kong-Joo, Choi, Jang Hyun, Suh, Se Won, Park, Seung Bum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021786/ https://www.ncbi.nlm.nih.gov/pubmed/30034693 http://dx.doi.org/10.1039/c6sc01279e |
Ejemplares similares
-
Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation
por: Jang, Jun Young, et al.
Publicado: (2019) -
Publisher Correction: Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation
por: Jang, Jun Young, et al.
Publicado: (2019) -
Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
por: Jang, Jun Young, et al.
Publicado: (2018) -
Revisiting PPARγ as a target for the treatment of metabolic disorders
por: Choi, Sun-Sil, et al.
Publicado: (2014) -
Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)